Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endosomal membrane phospholipid bilayer is a dynamic lipid structure that defines the boundary of endocytic vesicles, playing a central role in the sorting, trafficking, and degradation of internalized proteins and lipids (Gruenberg, J., 2020, Nature Reviews Molecular Cell Biology). It is characterized by a unique lipid composition, including phosphoinositides and bis(monoacylglycero)phosphate, which regulate the recruitment of various cytosolic proteins involved in membrane remodeling and fusion. In the context of infectious diseases, many viruses exploit the endosomal membrane as a site for cell entry, relying on the acidic luminal environment to trigger conformational changes in viral proteins that lead to membrane fusion (Hu, T. Y., et al., 2020, International Journal of Antimicrobial Agents). Pharmacological intervention often involves the use of lysosomotropic weak bases that accumulate in the endosome, raising the pH and thereby inhibiting viral entry or altering protein processing. Additionally, the endosomal membrane represents a major barrier for the delivery of macromolecular drugs, such as mRNA and siRNA, leading to the development of delivery systems designed to destabilize the bilayer and promote endosomal escape (Smith, S. A., et al., 2019, Bioconjugate Chemistry).
Drugs targeting the endosomal membrane typically act by increasing endosomal pH to inhibit pH-dependent viral fusion, or by physically disrupting the bilayer to facilitate the escape of therapeutic molecules into the cytosol.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal membrane phospholipid bilayer.